4.6 Review

Genetic Risk Stratification A Paradigm Shift in Prevention of Coronary Artery Disease

期刊

JACC-BASIC TO TRANSLATIONAL SCIENCE
卷 6, 期 3, 页码 287-304

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacbts.2020.09.004

关键词

cardiovascular genetics; coronary artery disease; genetic risk score for CAD; genome-wide association studies; prevention of CAD

资金

  1. Canadian Institutes of Health Research, CIHR [MOP P82810]
  2. Canada Foundation for Innovation, the CFI [11966]
  3. Dignity Health Foundation

向作者/读者索取更多资源

Coronary artery disease is a highly preventable pandemic, and genetic risk score may offer a potential solution to improve primary prevention.
Coronary artery disease (CAD) is a pandemic disease that is highly preventable as shown by secondary prevention. Primary prevention is preferred knowing that 50% of the population can expect a cardiac event in their lifetime. Risk stratification for primary prevention using the American Heart Association/American College of Cardiology predicted 10-year risk based on conventional risk factors for CAD is less than optimal. Conventional risk factors such as hypertension, cholesterol, and age are age-dependent and not present until the sixth or seventh decade of life. The genetic risk score (GRS), which is estimated from the recently discovered genetic variants predisposed to CAD, offers a potential solution to this dilemma. The GRS, which is derived from genotyping the population with a microarray containing these genetic risk variants, has indicated that genetic risk stratification based on the GRS is superior to that of conventional risk factors in detecting those at high risk and who would benefit most from statin therapy. Studies performed in >1 million individuals confirmed genetic risk stratification is superior and primarily independent of conventional risk factors. Prospective clinical trials based on risk stratification for CAD using the GRS have shown lifestyle changes, physical activity, and statin therapy are associated with 40% to 50% reduction in cardiac events in the high genetic risk group (20%). Genetic risk stratification has the advantage of being innate to an individual's DNA, and because DNA does not change in a lifetime, it is independent of age. Genetic risk stratification is inexpensive and can be performed worldwide, providing risk analysis at any age and thus has the potential to revolutionize primary prevention. (C) 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据